Early detection of DN, adoption of multifactorial interventions targeting the main risk factors (hyperglycaemia, hypertension, dyslipidemia and smoking), and use of agents with a renoprotective effect (ACE inhibitors and/or ARBs) do indeed slow the progression of renal disease. Here, ACE is linked to metabolic syndrome.